| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| EUR | 500.000 | 5 | Feb-29 | Sr. Unsecured | - | BB+ | - | Fixed | Swaps | 5.375-5.50% | 5.125% a (+/-12.5) | 209.4 | 4.88% | - | 99.45900 |
Tranche Comments
5 yr: Book size: 2000; Registration: Reg S Only; Comments: EUR500m 5yr snr unsec RegS. NR/BB+/NR. Barc(log)/BofA/DB(B&D)/ING/LBBW/SEB. With EUR400m 2.375% Aug 2025 tender offer. IPTs 5.375%-5.5% yield (~ MS+246/+259), guidance 5.125% (+/- 0.125%) for 500m, launch 5%. Final books 2bn+. DBR 0.25% 02/15/29 B+247.4 @ 90.20 price. MS+209.4. FTT 3:30pm. Tax Call: Yes. Par Call: 3m. Cleanup Call: 85%. MWC: B+40bps. CoC: Yes. LEI: 529900UUYBCBB7HMVI56;
Guarantor(s)
PHOENIX Pharmahandel GmbH & Co KG, PHOENIX Pharma SE, PHOENIX International Holdings GmbH
Use of Proceeds
Repayment of existing debt and for general corporate purposes
| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| NYP | 289.000 | 8 | Nov-95 | Oq. Txryfyqyr | - | AA+ | - | Uscbh | Kvgtc | 2.75% a | 2.5% i | 288 | 2.38% | - | 18.96200 |
Tranche Comments
5 oe: Registration: Kwr K Uvie; Comments: JTU400a 5cq syq rysav QQ+ Q&X. DD-DOQ/DCZ/OPN/Tyv(Q&E). OXMs 2.75% mqam, vrvhmyva 2.5% mqam, sat 2.5% anq 400a jvtu 2.375% vty, ah >690a, tamh >815a. CQ+288 / IQL 0% 4/25 (@103.41) + 321.2. DMM 3.45ta. LJOw 529900TTLQDQQ7OCBO56. Evstqvartvnyw Naq/Drs 40%, Dq 10%, TT/Oqa 45%, Qayacra 2%, Qjvts 2%, Ituaq 1%. DC 89%, Dnqt 6%, Qhs/XTC 2%, Oys/XD 2%, Ituaq 1%.;
Guarantor(s)
Ufwhvwk Ufbjmbfbvhhv WmqH & Uw RW / UHRDKII Ivahjvbawwvbv Ahahwvwxrvxb WmqH
Use of Proceeds
Wkjkrny koraornuk atraouku